Results 61 to 70 of about 3,166 (75)

The augmentative efficacy of second-generation anti-psychotics (SGA) to anti-depressants in treating treatment-resistant depression: a network meta-regression analysis. [PDF]

BMC Psychiatry
Bai B, Li Y, Chen X, Huang J, Chen Q, Du X, Huang C, Yang Y.   +7 more
europepmc   +1 more source

Real-world analysis of pharmacological treatments to prevent relapse after electroconvulsive therapy for major depressive disorder: A nationwide cohort study. [PDF]

Transl Psychiatry
Kronsell A, Nordenskjöld A, Bodén R, Mittendorfer-Rutz E, Reutfors J, Rossides M, Tiger M.   +6 more
europepmc   +1 more source

The efficacy and safety of pharmacological treatment for major depressive episode with mixed features specifier: a systematic review and meta-analysis. [PDF]

Psychol Med
Gao S, Chen Y, Liu J, Zhang Q, Zhao X, Liu B, Zhang Y, Li L, Wang G.   +8 more
europepmc   +1 more source

GLX351322-Loaded Nanoparticles Alleviate Chronic Stress-Induced Depressive Behaviors Through Inhibition of Ferroptosis and Oxidative Stress. [PDF]

Int J Nanomedicine
Wang T, An J, Fu X, Sun J, Li H, Han X, Yang W.   +6 more
europepmc   +1 more source

Insights for the Next Generation of Ketamine for the Treatment of Depressive Disorder. [PDF]

J Med Chem
Faustino Martins AC, Badenoch B, da Silva Gomes R.   +2 more
europepmc   +1 more source

Two-stage Bayesian network meta-analysis of individualized treatment rules for multiple treatments with siloed data. [PDF]

Stat Methods Med Res
Shen J, Moodie EE, Golchi S.
europepmc   +1 more source

Neuroleptic Malignant Syndrome with Low-dose Quetiapine After Venlafaxine Withdrawal: A Case Report. [PDF]

Turk Psikiyatri Derg
Özden HC, Gürel ŞC.
europepmc   +1 more source

Depressive disorders: systematic review of approved psychiatric medications (2009-April 2025) and pipeline phase 3 medications. [PDF]

BMC Psychiatry
IsHak WW, Hirsch D, Renteria S, Totlani J, Murphy N, Chang T, Abdelsalam R, Salem M, Meyer A, Keerthana S, Liu A, Contreras L, Tadros E, Hedrick R, Danovitch I, Pechnick RN.   +15 more
europepmc   +1 more source

Combined enriched environment and fluoxetine enhance myelin protein expression in the prefrontal cortex of a chronic unpredictable stress depression model. [PDF]

Behav Brain Funct
Gu J, Liu C, Li Y, Feng L, Geng M, Dong J, Han J, Zhao L, Shao Q, Wang HY, Wang CH.   +10 more
europepmc   +1 more source

Baseline medication load and long-term outcomes in COVID-19-hospitalized patients: results of the AUTCOVSTUDY. [PDF]

Front Public Health
Graf A, Reichardt B, Wagenlechner C, Krotka P, Traxler-Weidenauer D, Mildner M, Mascherbauer J, Aigner C, Auer J, Wendt R, Ankersmit HJ.   +10 more
europepmc   +1 more source